218 related articles for article (PubMed ID: 26370275)
1. FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia.
Bralet MC; Buchsbaum MS; DeCastro A; Shihabuddin L; Mitelman SA
Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):481-94. PubMed ID: 26370275
[TBL] [Abstract][Full Text] [Related]
2. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
[TBL] [Abstract][Full Text] [Related]
3. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.
Buchsbaum MS; Haznedar M; Newmark RE; Chu KW; Dusi N; Entis JJ; Goldstein KE; Goodman CR; Gupta A; Hazlett E; Iannuzzi J; Torosjan Y; Zhang J; Wolkin A
Schizophr Res; 2009 Oct; 114(1-3):161-71. PubMed ID: 19695836
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder.
Bralet MC; Mitelman SA; Goodman CR; Lincoln S; Hazlett EA; Buchsbaum MS
Alcohol Clin Exp Res; 2022 Jun; 46(6):994-1010. PubMed ID: 35451074
[TBL] [Abstract][Full Text] [Related]
6. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia.
Lehrer DS; Christian BT; Mantil J; Murray AC; Buchsbaum BR; Oakes TR; Byne W; Kemether EM; Buchsbaum MS
Am J Psychiatry; 2005 May; 162(5):931-8. PubMed ID: 15863795
[TBL] [Abstract][Full Text] [Related]
7. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
[TBL] [Abstract][Full Text] [Related]
8. Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children.
Hua C; Merchant TE; Li X; Li Y; Shulkin BL
J Nucl Med; 2015 Apr; 56(4):575-9. PubMed ID: 25745092
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
10. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.
Diehl-Schmid J; Grimmer T; Drzezga A; Bornschein S; Riemenschneider M; Förstl H; Schwaiger M; Kurz A
Neurobiol Aging; 2007 Jan; 28(1):42-50. PubMed ID: 16448722
[TBL] [Abstract][Full Text] [Related]
11. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
Kim IJ; Kim SJ; Kim YK
Acta Radiol; 2009 Dec; 50(10):1169-74. PubMed ID: 19922315
[TBL] [Abstract][Full Text] [Related]
12. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
[TBL] [Abstract][Full Text] [Related]
13. Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry.
Molina V; Hernández JA; Sanz J; Paniagua JC; Hernández AI; Martín C; Matías J; Calama J; Bote B
Psychiatry Res; 2010 Oct; 184(1):16-22. PubMed ID: 20832256
[TBL] [Abstract][Full Text] [Related]
14. Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury.
Zhang J; Mitsis EM; Chu K; Newmark RE; Hazlett EA; Buchsbaum MS
J Neurotrauma; 2010 Jan; 27(1):35-49. PubMed ID: 19715400
[TBL] [Abstract][Full Text] [Related]
15. Dissociating behavioral disorders in early dementia-An FDG-PET study.
Schroeter ML; Vogt B; Frisch S; Becker G; Seese A; Barthel H; Mueller K; Villringer A; Sabri O
Psychiatry Res; 2011 Dec; 194(3):235-244. PubMed ID: 22044532
[TBL] [Abstract][Full Text] [Related]
16. Hemisphere-specific episodic memory networks in the human brain: a correlation study between intracarotid amobarbital test and [(18)F]FDG-PET.
Akanuma N; Reed LJ; Marsden PK; Jarosz J; Adachi N; Hallett WA; Alarcón G; Morris RG; Koutroumanidis M
J Cogn Neurosci; 2009 Mar; 21(3):605-22. PubMed ID: 18564051
[TBL] [Abstract][Full Text] [Related]
17. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Yanase D; Matsunari I; Yajima K; Chen W; Fujikawa A; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):794-805. PubMed ID: 15759148
[TBL] [Abstract][Full Text] [Related]
18. Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies.
Kanda T; Ishii K; Uemura T; Miyamoto N; Yoshikawa T; Kono AK; Mori E
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2227-34. PubMed ID: 18661129
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
20. Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease.
Pascual B; Prieto E; Arbizu J; Marti-Climent J; Olier J; Masdeu JC
Stroke; 2010 Dec; 41(12):2889-93. PubMed ID: 21051671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
